Search research articles
Contact Us
Filters
Showing results (191-200 of 220) with videos related to
Page
of 22
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 31, 2026
Guidance for Liver Rehabilitation in Chronic Liver Disease
Shuji Terai, Hiroteru Kamimura, Yoichi Hiasa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 4, 2023
Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications
Taeang Arai, Hirokazu Takahashi, Yuya Seko, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 24, 2025
Impact of Model for End-stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates
Wen Hui Lim, Darren Jun Hao Tan, Kartik Mitra, et al.
Hepatology Communications
|
December 13, 2024
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
Hiroshi Ishiba, Hideki Fujii, Yoshihiro Kamada, et al.
Gastro Hep Advances
|
April 20, 2026
Sequential Fibrosis-4 Index and Mac-2 Binding Protein Glycosylation Isomer Combination Improve Detection of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Study
Asahiro Morishita, Yoshihiro Kamada, Yoshio Sumida, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 11, 2025
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-analysis
Ryan Yanzhe Lim, Faith Xin Ning Tan, Glenn Jun Kit Ho, et al.
Journal of Gastroenterology
|
March 23, 2026
Impact of cardiometabolic criteria on the pathogenesis of MASLD and diagnostic performance of non-invasive tests
Kazuhito Kawata, Hirokazu Takahashi, Taeang Arai, et al.
Journal of Gastroenterology and Hepatology
|
March 12, 2021
Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease
Michihiro Iwaki, Takaomi Kessoku, Anna Ozaki, et al.
Journal of Gastroenterology
|
September 5, 2015
The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus
Misuzu Ueyama, Nao Nishida, Masaaki Korenaga, et al.
Scientific Reports
|
July 12, 2018
A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
Takumi Kawaguchi, Katsutoshi Tokushige, Hideyuki Hyogo, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 220) with videos related to
Sort By:
Page
of 22
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 31, 2026
Guidance for Liver Rehabilitation in Chronic Liver Disease
Shuji Terai, Hiroteru Kamimura, Yoichi Hiasa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 4, 2023
Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications
Taeang Arai, Hirokazu Takahashi, Yuya Seko, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 24, 2025
Impact of Model for End-stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates
Wen Hui Lim, Darren Jun Hao Tan, Kartik Mitra, et al.
Hepatology Communications
|
December 13, 2024
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
Hiroshi Ishiba, Hideki Fujii, Yoshihiro Kamada, et al.
Gastro Hep Advances
|
April 20, 2026
Sequential Fibrosis-4 Index and Mac-2 Binding Protein Glycosylation Isomer Combination Improve Detection of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Study
Asahiro Morishita, Yoshihiro Kamada, Yoshio Sumida, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 11, 2025
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-analysis
Ryan Yanzhe Lim, Faith Xin Ning Tan, Glenn Jun Kit Ho, et al.
Journal of Gastroenterology
|
March 23, 2026
Impact of cardiometabolic criteria on the pathogenesis of MASLD and diagnostic performance of non-invasive tests
Kazuhito Kawata, Hirokazu Takahashi, Taeang Arai, et al.
Journal of Gastroenterology and Hepatology
|
March 12, 2021
Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease
Michihiro Iwaki, Takaomi Kessoku, Anna Ozaki, et al.
Journal of Gastroenterology
|
September 5, 2015
The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus
Misuzu Ueyama, Nao Nishida, Masaaki Korenaga, et al.
Scientific Reports
|
July 12, 2018
A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
Takumi Kawaguchi, Katsutoshi Tokushige, Hideyuki Hyogo, et al.
Page
of 22